Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma.
about
Bortezomib for the treatment of mantle cell lymphoma: an updateAdvancement in high dose therapy and autologous stem cell rescue in lymphomaMantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsTrial Watch: Proteasomal inhibitors for anticancer therapyImpact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.Proteasome inhibitors - molecular basis and current perspectives in multiple myeloma.Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicity.BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients.Guidelines for the management of diffuse large B-cell lymphoma.
P2860
Q26738940-5588BE7F-AB68-4586-97E3-F73FF587A4ACQ26795538-221D0CED-9B49-410D-97CE-155CBF78C934Q28075606-C2D7B25E-53C7-4CB2-A583-3D7508DE8EAEQ28082910-6F93476A-A7C7-44EB-9D47-4EA81004FE0BQ35588804-3486733A-8713-4C5F-ABE7-A89416E17B71Q38202977-B5858E92-A0DA-42E7-9FA6-ADC999205D44Q39013183-07072713-BFA0-4E57-BB35-29A20BA3D95DQ39067361-96EEF45C-5914-4A1B-9FCD-D53891B25014Q54708579-1F47E50C-3FDA-421B-82A9-FE25BF6F1ABA
P2860
Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Phase I/II study of bortezomib ...... rmed, or mantle cell lymphoma.
@ast
Phase I/II study of bortezomib ...... rmed, or mantle cell lymphoma.
@en
type
label
Phase I/II study of bortezomib ...... rmed, or mantle cell lymphoma.
@ast
Phase I/II study of bortezomib ...... rmed, or mantle cell lymphoma.
@en
prefLabel
Phase I/II study of bortezomib ...... rmed, or mantle cell lymphoma.
@ast
Phase I/II study of bortezomib ...... rmed, or mantle cell lymphoma.
@en
P2093
P1476
Phase I/II study of bortezomib ...... rmed, or mantle cell lymphoma.
@en
P2093
Basem M William
Fausto R Loberiza
Mary S Allen
Philip J Bierman
Robert Gregory Bociek
P304
P356
10.1016/J.BBMT.2014.01.004
P577
2014-01-14T00:00:00Z